MS-DETECT · ADS-MS-DETECT-2023

Project focused on utilizing the digital tool MSCopilot to identify the clinical progression of multiple sclerosis in patients at an early stage.

MS-DETECT: Early detection of Multiple Sclerosis progression with MSCopilot® ADS-MS-DETECT-2023

Sponsor: Ad Scientiam

Phase: IV

Status: Follow-up

Public study eligibility criteria

* Adult patients living with RRMS or SPMS, aged 30 to 65
* EDSS score between 2.5 to 6.5 points
* With a disease duration \> 5 years
* Clinically stable during the last 3 months before inclusion (no relapses, no disability progression)
* No change in the DMT\* during the last 3 months before inclusion
* Receiving optimal symptomatic treatments at baseline (clinician's judgment)
* Owns a personal smartphone which mobile operating system is above 14 for IOS (iPhone) and 8 for Android included with a good internet connexion
* Able to use a smartphone
* Able to read language in wich the mobile application is available and able to understand pictograms.
* Applicable to patients enrolled in France only: affiliated to a social security system.

* Medically unstable conditions that may hinder patient's ability to comply with the study procedures
* Inability to use a smartphone or MSCopilot® Detect application
* Patient with corrected visual acuity less than 4/10 (Monoyer) or 20/50 (Snellen at 20 feet) or +0,4 (LogMAR)
* Pregnancy and nursing women
* Persons under guardianship or curatorship
* Current drugs or/and alcohol abuse that could influence performance on the tests (clinician's judgment)
* Patients have participated in another clinical study within the previous 30 days of screening or are currently participating in another study that, in the opinion of the Investigator, might interfere with the patient's full participation in the study or confound the assessment of the patient or outcome of the study.